Uk-aesthetic-firsts

A History of UK Aesthetic Firsts
A History of UK Aesthetic Firsts

Since opening on Harley Street in 2014, PHI Clinic has introduced more aesthetic to the UK than any other clinic. From the first FDA-cleared energy device for acne (), to the first cold-fibre fractional laser cleared for all skin types (), to the world's first resurfacing laser (), our role as a UK launch for leading global manufacturers has shaped how is across the country.


This page documents that . It is structured in two parts: the PHI Clinic was first to bring to the UK, and the for which PHI Clinic has served as the UK launch venue or Key Leader anchor.

Why being first matters in medical aesthetics

When a device chooses a UK launch clinic, the decision is rarely about commercial reach. It is about clinical credibility, safety standards, and the expertise required to use a new responsibly in its days on the market.


Being as a UK launch partner means a has assessed the clinic's clinical governance, the experience of its lead practitioners, and its track record with comparable technologies. For our patients, the is meaningful: when a treatment is at PHI Clinic, it has been delivered by who have been by the device's developers, often before the wider UK market has access to it.


That said, newer is not better. A core part of our approach is each new technology before it. We introduce devices we believe improve patient outcomes, not simply because they are new.


Each of the devices below a UK first for PHI Clinic, with documented or launch dates and verifiable manufacturer .


PHI Clinic introduced to the UK in January 2014, the first of the FDA-cleared microwave-based for reduction of underarm sweat anywhere in the . The launch coincided with PHI opening on Harley Street. Since then, our clinical team has performed hundreds of procedures, building one of the most case series of any UK clinic.


miraDry uses precisely electromagnetic energy to permanently the sweat and odour glands in the underarm area. Two treatment sessions, spaced three months apart, are recommended to achieve results. Because the contain less than 2 percent of the body's sweat glands, treatment does not compromise the body's natural regulation.


PHI Clinic became the first UK clinic to install the Cutera laser system, as by Medicine . Distributed in the UK by Sigmacon, the excel V two precision wavelengths, 532nm and 1064nm, in a single platform, treatment of vascular conditions, benign pigmented lesions, and a wide of skin concerns from one device. The award-winning system has since become a of care for treating complex vascular and cases across the UK.


PHI Clinic was the first clinic in the UK to offer , the world's first and only energy device for the treatment of mild, moderate, and severe acne. AviClear uses 1726nm laser energy to selectively suppress gland activity, addressing acne at its source rather than masking .


PHI's role as the UK launch clinic reflects 's position as a Key Opinion Leader for Cutera, manufacturer. In Cutera's studies, 87 percent of with AviClear saw at least half of their acne clear at six months following the three-session protocol, a result class that has redefined the available to UK acne patients beyond conventional and oral .


PHI Clinic was the first UK clinic to install , the first cold-fibre fractional laser to receive FDA clearance for all skin types and tones. Operating at a 2910nm wavelength, UltraClear a cold laser beam that unwanted thermal damage to the skin, significantly reducing the risk associated with ablative laser resurfacing in darker skin types.


The treatment is particularly valuable for with skin types IV to VI, who have been by conventional ablative laser . In a single platform, addresses sun damage, age spots, fine OnabotulinumtoxinAAbobotulinumtoxinAIncobotulinumtoxinAPrabotulinumtoxinALetibotulinumtoxinARimabotulinumtoxinBHyaluronic Acid FillersCalcium Hydroxylapatite FillersPoly-L-lactic Acid FillersPolymethylmethacrylate FillersAutologous Fat GraftingForehead Lines TreatmentGlabellar Frown Lines TreatmentCrow's Feet TreatmentBunny Lines TreatmentChemical Brow LiftLip FlipGummy Smile CorrectionMasseter ReductionJaw SlimmingDimpled Chin SmoothingCobblestone Chin SmoothingNefertiti Neck LiftMicro-BotoxMesotoxHyperhidrosis TreatmentChronic Migraine ReliefBruxism TreatmentTMJ TreatmentCervical Dystonia TreatmentNeck Spasm TreatmentBlepharospasm TreatmentLip AugmentationLip ContouringCheekbone EnhancementTear Trough FillersNasolabial Fold SofteningMarionette Line FillersLiquid RhinoplastyNon-Surgical Nose JobJawline ContouringJawline DefinitionChin AugmentationTemple VolumisingHand RejuvenationAcne Scar Subcision Filling, pigmentation, uneven texture, scarring, and enlarged pores.


PHI Clinic was the first UK clinic to introduce , a needle-free jet system originally developed from satellite micro-propulsion research at Seoul . active ingredients into the dermis through a 150-micron nozzle at controlled depths between 0.2mm and 2.0mm, without needles, and without open wounds.


The system offers two distinct delivery modes. from a short distance, droplets that penetrate the skin barrier for superficial and active ingredient absorption. Micro-BOMB places the device in direct contact with the skin to solutions deeper into the dermis, with a micro-subcision effect that helps remodel scar tissue and stretch marks.


is particularly for with needle phobia and for treatments where dispersed delivery improves outcomes, skin rejuvenation, scar and stretch mark improvement, acne support, and scalp and hair protocols.


In May 2025, PHI Clinic became the UK launch partner for , described by its as the first portable, simultaneously-firing dual-wavelength resurfacing laser. is the named UK Key Leader for the device, as documented in Aesthetics Journal and Consulting Room.


1550nm and 1927nm wavelengths via proprietary technology, allowing both wavelengths to be delivered or in a single treatment pass. This means a single session can wrinkles, acne scars, pigmentation, melasma, and sun damage at skin depths, that traditionally required separate treatments or multiple .


Beyond being first to introduce devices, PHI Clinic has been chosen by leading manufacturers as the UK launch venue for new technologies, and Dr Tapan Patel holds Key Leader positions across multiple advanced platforms.

ResurFX: UK industry launch hosted at PHI Clinic, March 2015

In March 2015, Lumenis, the world's largest energy-based medical device company for aesthetic, surgical, and ophthalmology applications, PHI Clinic as the UK launch venue for the ResurFX non-ablative laser system. The industry event was by The Harley Street Journal and included a live by , described in the as "a recognised industry leader for facial rejuvenation treatments."


uses a 1565nm fibre laser to skin resurfacing, stimulating collagen production with minimal . The choice of PHI Clinic as the launch venue, less than 18 months after the clinic opened, reflected the of Dr Tapan clinical authority in facial .


, and founder of PHI Clinic, is a UK Key Opinion Leader for , the invasive laser skin tightening treatment using the Eufoton LASEmaR 1500, as announced in Aesthetics Journal. Endolift was featured on 5's 10 Years Younger in 10 Days, with Dr Tapan Patel the as the non-surgical doctor on the .


PHI Clinic has also hosted dedicated UK events for EndoliftX, the platform, with Dr Tapan Patel opening the discussions on the device's clinical applications.


Beyond individual firsts, PHI Clinic houses one of the largest collections of medical devices of any clinic in the UK. The clinic operates across four floors at 102 Harley Street, treatment pods, theatres, laser rooms, and a dedicated training where international and global cosmetic brands come to learn or showcase best practices in aesthetics.


This of technology matters clinically. It allows our team to build bespoke plans, selecting from a wide range of modalities (injectable, laser, ultrasound, radiofrequency, and regenerative) based on what is right for the patient rather than what is available in a device range.


PHI Clinic's role as a UK launch partner is anchored by the authority of our team. , our Medical Director and founder, is a Global Key Opinion Leader for (the manufacturers of BOTOX® and Juvéderm®), a Key Opinion Leader for Cutera (the parent of and ), the named UK Key Leader for , and a UK Key Opinion Leader for . He has clinicians internationally and was the first non-surgical doctor invited to deliver an exclusive lecture to members of the British of Plastic Surgeons (BAAPS), at their annual conference in October 2018.


This concentration of Key across device is part of why global brands consistently choose PHI Clinic as a UK launch partner. Bringing a new to market in a regulated environment requires not just early access, but the clinical expertise to use it safely and effectively from day one.


For patients, our history of UK firsts into something practical: access to genuinely advanced treatments, delivered by clinicians who have been by the people who developed them.


It also means a more considered to . Because we work closely with manufacturers from the earliest stages of UK availability, our team has a deeper understanding of which patients each technology is genuinely suited for, and equally, when it is not the right choice. That depth of the natural-looking, results PHI Clinic is known for.


If you are considering an advanced treatment and would like to which option is most appropriate for you, a consultation with our clinical team is the best starting point.




Frequently asked questions

PHI Clinic on Harley Street was the first clinic in the UK to offer AviClear, the world's first energy device for the treatment of mild, moderate, and severe acne.


miraDry, the for reduction of underarm sweat, became available to UK at PHI Clinic in January 2014.


PHI Clinic on Harley Street was the first UK clinic to install UltraClear, the first fractional laser to FDA for all skin types and tones.


PHI Clinic was the first UK clinic to introduce NovoJet, a jet injection system active into the dermis at controlled depths through 150-micron technology.


PHI Clinic was the UK launch partner for in May 2025, with Dr Tapan Patel serving as the named UK Key Leader for the device.


The ResurFX fractional non-ablative laser system was to the UK aesthetic at PHI Clinic on Harley Street in March 2015, with Dr Tapan Patel performing the live at the industry launch event.


select launch partners based on governance, the of lead practitioners, and the clinic's track record with comparable . PHI Clinic's Director, Dr Tapan Patel, holds Key Opinion Leader positions with Aesthetics, Cutera, Multifrax, and Endolift, and the clinic operates one of the largest device collections of any aesthetic practice in the UK.


Not automatically. At PHI Clinic, every new is assessed before being introduced into patient care. The fact that a device is new does not make it the right choice for every patient, and a core part of our process is identifying the that genuinely fits each individual, regardless of whether it is the latest available.


can be booked by calling or via our online enquiry form. During your consultation, our clinical team will your concerns and goals, and recommend the best suited to you.


Disclaimer: Results may vary from person to person and treatment to treatment.


© 2024 PHI Clinic


© 2024 PHI Clinic